Oncternal Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Cash & Equivalents	197.77	191.7	44.87	31.33	15.18	20.6
Cash & Short-Term Investments	197.77	191.7	44.87	31.33	15.18	20.6
Cash Growth	11.29%	327.21%	43.24%	106.40%	-26.32%	-
Accounts Receivable	34.82	22.52	23.58	23.44	1.05	0.79
Other Receivables	-	0.94	0.54	-	-	-
Receivables	34.82	23.46	24.12	27.1	1.05	0.79
Inventory	11.44	7.74	5.83	2.54	1.58	1.56
Prepaid Expenses	-	0.09	-	-	-	-
Other Current Assets	1.51	0.01	2.18	0.23	2.95	0.8
Total Current Assets	245.53	223	77	61.2	20.75	23.75
Property, Plant & Equipment	141.57	126.82	118.78	9.15	8.97	9.08
Other Long-Term Assets	1.68	4.26	0.25	0.2	0.2	0.2
Total Assets	388.79	354.08	196.04	70.55	29.92	33.04
Accounts Payable	18.68	10.49	7.78	7.07	5.73	10.18
Accrued Expenses	6.81	1.02	4.45	9.09	0.34	0.15
Current Income Taxes Payable	-	1.78	-	-	2.52	0.61
Other Current Liabilities	5.61	1.5	2.02	-	0.7	0.13
Total Current Liabilities	31.1	14.78	14.25	16.16	9.29	11.07
Long-Term Debt	0.85	0.85	1.01	3.97	3.46	3.47
Long-Term Deferred Tax Liabilities	4.17	2.95	0.43	0.24	0.29	0.16
Other Long-Term Liabilities	-	-0	-	-	-0	-0
Total Liabilities	36.48	18.86	15.82	20.38	13.04	14.7
Common Stock	137.77	137.77	99.85	39.48	16.88	18.34
Additional Paid-In Capital	-	144.44	54.33	-	-	-
Retained Earnings	-	52.71	25.74	10.68	-	-
Comprehensive Income & Other	214.22	-	-	0	-	-
Total Common Equity	351.99	334.92	179.92	50.16	16.88	18.34
Minority Interest	0.32	0.3	0.29	-	-	-
Shareholders' Equity	352.3	335.22	180.22	50.16	16.88	18.34
Total Liabilities & Equity	388.79	354.08	196.04	70.55	29.92	33.04
Total Debt	0.85	0.85	1.01	3.97	3.46	3.47
Net Cash (Debt)	196.92	190.85	43.87	27.35	11.72	17.13
Net Cash Growth	11.44%	335.09%	60.37%	133.38%	-31.57%	-
Net Cash Per Share	15.84	15.38	4.64	6.93	6.94	9.34
Filing Date Shares Outstanding	13.77	13.78	9.98	9.98	1.69	1.83
Total Common Shares Outstanding	13.77	13.78	9.98	3.95	1.69	1.83
Working Capital	214.44	208.22	62.75	45.03	11.46	12.68
Book Value Per Share	25.56	24.31	18.02	12.71	10.00	10.00
Tangible Book Value	351.99	334.92	179.92	50.16	16.88	18.34
Tangible Book Value Per Share	25.56	24.31	18.02	12.71	10.00	10.00
Buildings	-	121.47	121.47	-	-	-
Machinery	-	18.86	7.98	11.49	10.45	9.85

Updated Sep 4, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.